Discover An Italian Experience with Mechanochemical Ablation of the Saphenous Vein Since 20121
99.5%
Technical
Success Rate
92.4%
Freedom from
Recanalization Rate
- Single centre, retrospective study of 329 patients who underwent treatment of saphenous venous reflux using the ClariVein OC infusion catheter.
- Treatment using ClariVein OC maintains effective success rates at 5 year follow up: high technical success rate (99.5%) and freedom from recanalization rates 92.4% at 5 years.
- Using ClariVein OC may offer the patient the benefit of minimal pain and brief recovery time.^
NEW ARTICLE: Mechanochemical ablation with ClariVein OC: A “first choice” treatment option [27 April 2023]
1. Mirandola, M., Griso, A., Migliara, B, Cappellari, TF, Giovannini, F., Lino, M. An Italian experience with mechanochemical ablation of the saphenous vein since 2012. J Vasc Surg: V&LD 2020; 1-7. DOI: https://doi.org/10.1016/j.jvsv.2020.01.006
^ Elias, S., Lam, Y. L., & Wittens, C. H. A. (2013, March). Mechanochemical Ablation (MOCA): Status and Results [greater than two years data]. Phlebology, Vol. 28 (suppl. 1), pp. 10-14.DOI: 10.117/026835513477787
Important Info: This product page is intended only for an audience outside of the United States as the ClariVein OC Infusion Catheter is not approved or available for sale in the United States. By staying on this page you acknowledge you are not viewing this information for use within the United States.